Cf 301-105

Omaha, Nebraska 68198

0 studies enrolling now · 2 studies all time

What they study most

Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia), Staphylococcus Aureus Endocarditis

Studies at this site

• Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase — Stopped early
• A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects — Completed